Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Ryan MacDonald

Docebo Sees Enterprise Demand Rebound as AI and Skills Tools Fuel Growth

Docebo (NASDAQ:DCBO) is seeing improved enterprise demand after addressing product and go-to-market gaps that weighed on its business in 2025, Brandon Farber of Docebo said during a Needham fireside chat hosted by analyst Ryan MacDonald. Farber described Docebo as a learning management system provi

MarketBeat

Does the nearby exoplanet TRAPPIST-1e support life? New James Webb Space Telescope data could help us find out

The James Webb Space Telescope has investigated the "Goldilocks zone" planet TRAPPIST-1e to search for a potential atmosphere and hints of habitability.

Space

Scottish researchers discover possible atmosphere around Earth-like planet

New research has identified a possible atmosphere around an Earth-sized planet about 40 light years away.

The National (Scotland)

From analysis to the latest developments in health,
read the most diverse news in one place.

Possible atmosphere identified around Earth-like exoplanet, sparking life debate

Researchers from the University of St Andrews made the discovery.

Evening Standard

Astronomers make key discovery about planet within ‘habitable zone’

The team spent more than a year carefully correcting the data

The Independent UK

McGraw Hill Transitions To Digital As Analyst Highlights 'Recession-Resistant Business'

As the education sector increasingly turns towards digital solutions, companies that adapt swiftly are poised to capture significant market share. McGraw Hill Inc. (NYSE:MH) , a longstanding name in educational publishing, is making strategic moves to redefine its place in this evolving landscape. The company raised $414.6 million in its…

Benzinga

Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say

Shares of Hims Hers Health Inc (NYSE:HIMS) are under pressure Tuesday, after the company reported downbeat second-quarter revenues.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Omada Health Analysts Say 'Buy' — While It's Still Below IPO Price

Canaccord Genuity and Needham analysts initiate coverage of Omada Health Inc (NASDAQ:OMDA) with a Buy rating.

Benzinga

Navigating 15 Analyst Ratings For Duolingo

Throughout the last three months, 15 analysts have evaluated Duolingo (NASDAQ:DUOL), offering a diverse set of opinions from bullish to bearish.

Benzinga

Liquid Web launches new GPU hosting service for AI and HPC — and users can access a range of Nvidia GPUs (including H100s)

Liquid Web has unveiled the launch of a new GPU hosting service designed to keep pace with growing high-performance computing (HPC) requirements.

TechRadar

James Webb Space Telescope suggests this exoplanet is our 'best bet' at finding an alien ocean

James Webb Space Telescope data suggests the exoplanet LHS 1140 b is a water world in its star's habitable zone that sports a lovely, temperate ocean.

Space

8 Coupa Software Analysts Weigh In After Stock Spikes Following Upbeat Q2 Results

Shares of Coupa Software Inc (NASDAQ: COUP) spiked in Tuesday's after-hours session, after the company reported upbeat financial results and announced a $100 million buyback. Wells Fargo On Coupa Software

Benzinga

Paycom Gets Thumbs Up From Analysts Post Q2 Beat; Shares Pop

Paycom Software, Inc (NYSE: PAYC) clocked 31% revenue&n

Benzinga

Here's Why Accolade Shares Are Trading Higher Today

Needham analyst Ryan MacDonald reiterated a Buy rating on Accolade, Inc (NASDAQ:ACCD) with a price target of $12. Following a problematic 4QF22, he noted that Accolade bounced back nicely in 1QF23 as the company beat management's initial outlook for FY23 revenue and adjusted EBITDA. While early in the selling season, ACCD won more new business in 1QF23 than…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Read How Analysts Reacted To Paycom Software's Q1 Results

Analysts reiterated their ratings on Paycom Software, Inc (NYSE:PAYC) post Q1 results. Needham analyst Ryan MacDonald reiterated the Buy rating and $450 price target on Paycom Software following the company's stellar start to FY22, in which revenue and adjusted EBITDA exceeded consensus expectations. PAYC put up a sizeable 1Q22 beat and raise driven by solid sales…

Benzinga

5 Analysts Takeaways As Chegg's Stock Crashes After Q1 Earnings Report

Chegg Inc (NYSE: CHGG) reported its first-quarter adjusted earnings of 32 cents per share, ahead of the consensus estimates of 24 cents per share. Net revenues missed Street expectations and the company slashed its full-year revenue and adjusted EBITDA guidance.

Benzinga

Teladoc Analysts React To Shocking Q1 Losses, Rising BetterHelp Costs

A brutal 12 months for Teladoc Health Inc (NYSE: TDOC) went from bad to much worse on Thursday when the stock dropped another 43% after the company reported much larger-than-expected losses in the first quarter and slashed its 2022 guidance.

Benzinga

Read How Analysts Reacted To Paycom Software's Q4 Results

Analyst opinions remain divided over Paycom Software Inc (NYSE:PAYC) post Q4 results. Piper Sandler analyst Arvind Ramnani raised the price target on Paycom to $505 from $498 (40% upside) and reiterated an Overweight. Paycom's Q4 results "were robust all-around" as revenue came in well above expectations driven by a healthy demand environment, Ramnani says. Stifel analyst Brad…

Get all your
news in one place.

100's of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.